SCHEMBL5095871

SCHEMBL5095871

CC(C)(C)CC(=O)Nc1ccc(OCc2ccc(F)c(F)c2)cc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.50
MAOA P21397 3/20 0.50
KCNQ3 O43525 1/20 0.43
KCNQ2 O43526 1/20 0.43
ACHE P22303 1/20 0.42
PPARA Q07869 1/20 0.41
HDAC1 Q13547 3/20 0.41
HDAC2 Q92769 2/20 0.41
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
ANO1 Q5XXA6 2/20 0.40
MME P08473 1/20 0.40
ACE P12821 1/20 0.40
CPA1 P15085 1/20 0.40
ACE2 Q9BYF1 1/20 0.40
LNPEP Q9UIQ6 1/20 0.39
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPK13 O15264 1/20 0.38
MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5087391 0.90 HDAC1 (0.52) MAOBMAOAKCNQ3KCNQ2HDAC1
SCHEMBL5090792 0.81 KCNQ2 (0.55) MAOBMAOAKCNQ3KCNQ2ACHE
SCHEMBL1578465 0.80 MAOA (0.49) MAOBMAOAKCNQ2ACHEPPARA
SCHEMBL5096503 0.78 MAOB (0.48) MAOBMAOAKCNQ3KCNQ2ACHE
SCHEMBL12199660 0.78 ALDH1A1 (0.52) HDAC1HDAC2ADORA2AADORA1HTT
SCHEMBL5096446 0.76 HDAC1 (0.40) KCNQ3KCNQ2HDAC1HDAC2ADORA2A
SCHEMBL5090804 0.76 HDAC1 (0.54) MAOBMAOAKCNQ3KCNQ2HDAC1
SCHEMBL5087383 0.75 HDAC1 (0.56) MAOBMAOAHDAC1HDAC2
SCHEMBL5090204 0.75 HDAC1 (0.53) MAOBMAOAKCNQ3KCNQ2HDAC1
SCHEMBL1826956 0.75 MAOB (0.52) MAOBMAOAACHEPPARAANO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US claimed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 MAOB 808/4885MAOA 1086/4885KCNQ3 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.